Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage
Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage Strongly agree
Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage Agree
Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage Neutral
Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage Disagree
Describe current perspectives regarding early, efficacious treatment of active MS disease to prevent irreversible neurologic damage Strongly disagree
Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans
Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans Strongly agree
Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans Agree
Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans Neutral
Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans Disagree
Compare the mechanisms of action and efficacy of currently available and emerging MS treatments in order to better individualize patient treatment plans Strongly disagree
Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT
Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT Strongly agree
Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT Agree
Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT Neutral
Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT Disagree
Design therapeutic strategies encompassing patient efficacy outcomes, safety and tolerability considerations, reimbursement strategies and consideration, as well as patient preferences, when selecting a DMT Strongly disagree
Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS
Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS Strongly agree
Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS Agree
Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS Neutral
Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS Disagree
Implement a multidisciplinary treatment strategy involving shared decision-making along with appropriate patient resources to improve the management of patients with MS Strongly disagree